Single-domain antibody-SH3 fusions for efficient neutralization of HIV-1 Nef functions

Journal of Virology

Volumn 86, Issue 9, 2012, Pages 4856-4867

  Bouchet, Jérôme ^a   Hérate, Cécile ^a   Guenzel, Carolin A ^a   Vérollet, Christel ^b,c   Järviluoma, Annika ^d   Mazzolini, Julie ^a   Rafie, Salomeh ^a   Chames, Patrick ^e   Baty, Daniel ^e   Saksela, Kalle ^d   Niedergang, Florence ^a   Maridonneau Parini, Isabelle ^b,c   Benichou, Serge ^a  

^a INSTITUT COCHIN   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CD4 ANTIGEN; HEMATOPOIETIC CELL KINASE; HYBRID PROTEIN; LEUCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; PROTEIN KINASE LCK; SINGLE DOMAIN ANTIBODY SH3 FUSION PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LOCALIZATION; GIANT CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL SYNAPSE; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; ROSETTE FORMATION; T LYMPHOCYTE; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANTIGENS, CD4; ANTIVIRAL AGENTS; CELL LINE; DOWN-REGULATION; GENE ORDER; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV-1; HUMANS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MACROPHAGES; MOLECULAR SEQUENCE DATA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PHAGOCYTOSIS; PROTEIN BINDING; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-HCK; RECOMBINANT FUSION PROTEINS; SINGLE-CHAIN ANTIBODIES; SRC HOMOLOGY DOMAINS; TRANSCRIPTION FACTOR AP-1;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84861318507     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06329-11     Document Type: Article

References (44)

1. Arhel NJ, Kirchhoff F. 2009. Implications of Nef: host cell interactions in viral persistence and progression to AIDS. Curr. Top. Microbiol. Immunol. 339:147-175.
2. Bolte S, Cordelières FP. 2006. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224:213-232.
3. Bouchet J, et al. 2011. Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody. Blood 117:3559-3568.
4. Breuer S, et al. 2011. Molecular design, functional characterization and structural basis of a protein inhibitor against the HIV-1 pathogenicity factor Nef. PLoS One 6:e20033.
5. Burtey A, et al. 2007. Dynamic interaction of HIV-1 Nef with the clathrin-mediated endocytic pathway at the plasma membrane. Traffic 8:61-76.
6. Cougoule C, et al. 2005. Activation of the lysosome-associated p61Hck isoform triggers the biogenesis of podosomes. Traffic 6:682-694.
7. Cougoule C, et al. 2010. Three-dimensional migration of macrophages requires Hck for podosome organization and extracellular matrix proteolysis. Blood 115:1444-1452.
8. Dikeakos JD, et al. 2010. Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef action. Mol. Biol. Cell 21:3279-3292.
9. Foster JL, Denial SJ, Temple BRS, Garcia JV. 2011. Mechanisms of HIV-1 Nef function and intracellular signaling. J. Neuroimmune Pharmacol. 6:230-246.
10. Gavegnano C, Schinazi RF. 2009. Antiretroviral therapy in macrophages: implication for HIV eradication. Antivir. Chem. Chemother. 20:63-78.
11. Guiet R, et al. 2008. Hematopoietic cell kinase (Hck) isoforms and phagocyte duties-from signaling and actin reorganization to migration and phagocytosis. Eur. J. Cell Biol. 87:527-542.
12. Haller C, Rauch S, Fackler OT. 2007. HIV-1 Nef employs two distinct mechanisms to modulate Lck subcellular localization and TCR induced actin remodeling. PLoS One 2:e1212.
13. Hanna Z, et al. 1998. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95: 163-175.
14. Helming L, Gordon S. 2009. Molecular mediators of macrophage fusion. Trends Cell Biol. 19:514-522.
15. Hiipakka M, Huotari P, Manninen A, Renkema GH, Saksela K. 2001. Inhibition of cellular functions of HIV-1 Nef by artificial SH3 domains. Virology 286:152-159.
16. Hiipakka M, Poikonen K, Saksela K. 1999. SH3 domains with high affinity and engineered ligand specificities targeted to HIV-1 Nef. J. Mol. Biol. 293:1097-1106.
17. Horenkamp FA, et al. 2011. Conformation of the dileucine-based sorting motif in HIV-1 Nef revealed by intermolecular domain assembly. Traffic 12:867-877.
18. Horita DA, et al. 1998. Solution structure of the human Hck SH3 domain and identification of its ligand binding site. J. Mol. Biol. 278:253-265.
19. Janvier K, et al. 2003. HIV-1 Nef stabilizes the association of adaptor protein complexes with membranes. J. Biol. Chem. 278:8725-8732.
20. Laguette N, et al. 2009. Nef-induced CD4 endocytosis in human immunodeficiency virus type 1 host cells: role of p56lck kinase. J. Virol. 83:7117-7128.
21. Laguette N, Benichou S, Basmaciogullari S. 2009. Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity. J. Virol. 83:1093-1104.
22. Laguette N, Brégnard C, Benichou S, Basmaciogullari S. 2010. Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins. Mol. Aspects Med. 31:418-433.
23. Lee CH, et al. 1995. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J. 14:5006-5015.
24. Madrid R, et al. 2005. Nef-induced alteration of the early/recycling endosomal compartment correlates with enhancement of HIV-1 infectivity. J. Biol. Chem. 280:5032-5044.
25. Manders EM, Stap J, Brakenhoff GJ, van Driel R, Aten JA. 1992. Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy. J. Cell Sci. 103:857-862.
26. Mangasarian A, Piguet V, Wang JK, Chen YL, Trono D. 1999. Nefinduced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J. Virol. 73:1964-1973.
27. Mayer BJ. 2001. SH3 domains: complexity in moderation. J. Cell Sci. 114:1253-1263.
28. Mazzolini J, et al. 2010. Inhibition of phagocytosis in HIV-1-infected macrophages relies on Nef-dependent alteration of focal delivery of recycling compartments. Blood 115:4226-4236.
29. Noviello CM, Benichou S, Guatelli JC. 2008. Cooperative binding of the class I major histocompatibility complex cytoplasmic domain and human immunodeficiency virus type 1 Nef to the endosomal AP-1 complex via its mu subunit. J. Virol. 82:1249-1258.
30. Orenstein JM. 2001. The macrophage in HIV infection. Immunobiology 204:598-602.
31. Orenstein JM, Wahl SM. 1999. The macrophage origin of the HIVexpressing multinucleated giant cells in hyperplastic tonsils and adenoids. Ultrastruct. Pathol. 23:79-91.
32. Piguet V, et al. 2000. HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nat. Cell Biol. 2:163-167.
33. Roeth JF, Williams M, Kasper MR, Filzen TM, Collins KL. 2004. HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail. J. Cell Biol. 167:903-913.
34. Rudolph JM, Eickel N, Haller C, Schindler M, Fackler OT. 2009. Inhibition of T-cell receptor-induced actin remodeling and relocalization of Lck are evolutionarily conserved activities of lentiviral Nef proteins. J. Virol. 83:11528-11539.
35. Saksela K, Cheng G, Baltimore D. 1995. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14:484-491.
36. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2:338-342.
37. Thoulouze MI, et al. 2006. Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity 24:547-561.
38. Van Goethem E, et al. 2011. Macrophage podosomes go 3D. Eur. J. Cell Biol. 90:224-236.
39. Van Goethem E, Poincloux R, Gauffre F, Maridonneau-Parini I, Le Cabec V. 2010. Matrix architecture dictates three-dimensional migration modes of human macrophages: differential involvement of proteases and podosome-like structures. J. Immunol. 184:1049-1061.
40. Vérollet C, et al. 2010. HIV-1 Nef triggers macrophage fusion in a p61Hck- and protease-dependent manner. J. Immunol. 184:7030-7039.
41. Williams M, Roeth JF, Kasper MR, Filzen TM, Collins KL. 2005. Human immunodeficiency virus type 1 Nef domains required for disruption of major histocompatibility complex class I trafficking are also necessary for coprecipitation of Nef with HLA-A2. J. Virol. 79:632-636.
42. Wonderlich ER, Williams M, Collins KL. 2008. The tyrosine binding pocket in the adaptor protein 1 (AP-1) mu1 subunit is necessary for Nef to recruit AP-1 to the major histocompatibility complex class I cytoplasmic tail. J. Biol. Chem. 283:3011-3022.
43. Xu W, et al. 2009. HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat. Immunol. 10:1008-1017.
44. Yewdell JW, Hill AB. 2002. Viral interference with antigen presentation. Nat. Immunol. 3:1019-1025.